ZEAL:CPH
Zealand Pharma A/S
၂၂၉.၄၀ DKK
arrow_upward
+၀.၉၂%(+၂.၁၀) 1D
အောက် ၁၅, GMT+၂ ၁၇:၀၀:၀၀ · DKK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ZEAL...
Open
၂၂၇.၀၀ DKK
High
၂၂၉.၄၀ DKK
Low
၂၂၃.၁၀ DKK
Mkt. cap
ဋေ ၁.၆၆ ထ
Avg. vol.
၄.၀၃ သိန်း
Volume
၃.၈၄ သိန်း
52-wk high
၅၅၆.၀၀ DKK
52-wk low
၂၂၃.၁၀ DKK
Shares outstanding
၇.၁၆ ကုဋေ
No. of employees
၅၇၈
Open
၂၂၇.၀၀ DKK
High
၂၂၉.၄၀ DKK
Low
၂၂၃.၁၀ DKK
Mkt. cap
ဋေ ၁.၆၆ ထ
Avg. vol.
၄.၀၃ သိန်း
Volume
၃.၈၄ သိန်း
52-wk high
၅၅၆.၀၀ DKK
52-wk low
၂၂၃.၁၀ DKK
Shares outstanding
၇.၁၆ ကုဋေ
No. of employees
၅၇၈
News stories
From web sources and news partners
Investing.com Canada
·
ပြီးခဲ့သည့် ၂ ရက်
Zealand Pharma partners with Generate on AI drug development By Investing.com
Stock Titan
·
ပြီးခဲ့သည့် ၂ ရက်
Up to nearly $1.2B in milestones is tied to Generate's planned AI research on obesity drugs.
Profile
Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. The company's head office is situated in Søborg near Copenhagen, and it has close to 200 employees. In 2018, they opened a subsidiary in the US. Zealand Pharma forms part of the Danish-Swedish life science cluster Medicon Valley. Wikipedia
About Zealand Pharma A/S